🇺🇸 FDA
Patent

US 9176122

Biomarkers for predicting response to immunosuppressive therapy

granted A61PA61P31/18

Quick answer

US patent 9176122 (Biomarkers for predicting response to immunosuppressive therapy) held by United States Department of Veteran Affairs expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Department of Veteran Affairs
Grant date
Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61P, A61P31/18